A Tunisian pharmaceutical company specializing in the development and manufacture of medications and dietary supplements in dry forms in accordance with Good Manufacturing Practices (GMP).
SYNBIOZ Laboratories have obtained the license to manufacture medicines for human use in February 2026 from the Tunisian Ministry of Public Health.
SYNBIOZ Laboratories is gradually establishing its development, manufacturing, and quality control operations, with the goal of building a relationship of trust with authorities, professional partners, and stakeholders in the healthcare sector.
Learn more
High-Quality Standards
A Tunisian company specializing in dry forms, initially focused on drug development and, since 2025, on the marketing of a range of dietary supplements.
An initial line of dietary supplements developed in accordance with good manufacturing practices and applicable standards.
Restore gastric well-being without nausea or vomiting.
Helps reduce inflammation and pain by targeting leukotrienes.
Our quality system is built into the design of the industrial facility from the outset, based on national and international standards applicable to pharmaceutical facilities.
A quality, safety, and environmental system structured in accordance with international standards.
Good Manufacturing Practices and Good Hygiene Practices are integrated into the design of our production site.
Our team is available to assist you with any partnership inquiries or requests for information about our products.
Lot No. 4, Menzel Chaker Industrial Zone, Sfax 3020, Tunisia.
(+216) 24 126 412
(+216) 29 444 778
(+216) 24 126 436
synbioz@synbioz.tn
